|
Market Closed -
Nasdaq
23:00:00 30/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 31.02 USD | -2.94% |
|
-0.61% | -12.67% |
Company Valuation: Cogent Biosciences, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 341.9 | 808 | 506.4 | 862.2 | 5,404 | 5,384 | - | - |
| Change | - | 136.3% | -37.32% | 70.26% | 526.72% | -0.36% | - | - |
| Enterprise Value (EV) 1 | 341.9 | 808 | 506.4 | 862.2 | 4,742 | 5,254 | 5,226 | 5,058 |
| Change | - | 136.3% | -37.32% | 70.26% | 449.94% | 10.82% | -0.54% | -3.22% |
| P/E | -4.59x | -4.84x | -2.43x | -4.02x | -16.4x | -13.9x | -27.8x | 40.7x |
| PBR | - | - | 1.81x | 3.36x | 8.99x | 13.7x | 13.6x | 10.4x |
| PEG | - | -0.2x | -1.94x | 0.2x | -1.4x | -4.19x | 0.6x | -0x |
| Capitalization / Revenue | - | - | - | - | - | 899x | 19x | 7.07x |
| EV / Revenue | - | - | - | - | - | 877x | 18.4x | 6.64x |
| EV / EBITDA | - | - | -2.46x | -3.15x | -14.3x | -12.8x | -18.7x | 152x |
| EV / EBIT | -4.53x | -5.47x | -2.43x | -3.12x | -14.2x | -12.7x | -22.2x | 34x |
| EV / FCF | - | - | -3.24x | -4.14x | -17.8x | -16.5x | -35.4x | 40.1x |
| FCF Yield | - | - | -30.9% | -24.2% | -5.61% | -6.06% | -2.82% | 2.5% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -1.87 | -2.39 | -2.42 | -1.94 | -2.16 | -2.232 | -1.114 | 0.7613 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | - | - | - | - | - | 5.989 | 283.7 | 761.4 |
| EBITDA 1 | - | - | -205.9 | -273.5 | -330.8 | -409 | -280.2 | 33.24 |
| EBIT 1 | -75.55 | -147.8 | -208.1 | -275.9 | -333.4 | -412.8 | -234.9 | 148.9 |
| Net income 1 | -72.27 | -140.2 | -192.4 | -255.9 | -328.9 | -395.3 | -216.9 | 145.1 |
| Net Debt 1 | - | - | - | - | -662 | -129.6 | -158.1 | -326.4 |
| Reference price 2 | 8.58 | 11.56 | 5.88 | 7.80 | 35.52 | 31.02 | 31.02 | 31.02 |
| Nbr of stocks (in thousands) | 39,851 | 69,893 | 86,124 | 110,539 | 152,128 | 173,569 | - | - |
| Announcement Date | 3/15/22 A | 3/14/23 A | 2/26/24 A | 2/25/25 A | 2/17/26 A | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -13.9x | 877.4x | -12.85x | -.--% | 5.38B | |
| 16.87x | 6.34x | 12.15x | 1.77% | 63.77B | |
| 30.14x | 8.25x | 27.02x | 0.04% | 56.37B | |
| 37.48x | 6.65x | 19.86x | 0.86% | 54.62B | |
| 34.85x | 3.31x | 14.29x | -.--% | 44.06B | |
| 48.85x | 5.63x | 30.81x | -.--% | 42.11B | |
| -19.86x | 192.36x | -21.16x | -.--% | 41B | |
| 47.33x | 8.41x | 28.18x | -.--% | 34.92B | |
| 32x | 8.13x | 21.15x | 0.41% | 32.82B | |
| -71.62x | 13.03x | -68.47x | -.--% | 24.7B | |
| Average | 14.21x | 112.95x | 5.10x | 0.31% | 39.97B | |
| Weighted average by Cap. | 21.16x | 37.80x | 10.91x | 0.44% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- COGT Stock
- Valuation Cogent Biosciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
